Recent Updates
Recently added Catalysts
SINT Positive Sentiment

SINTX Technologies Regains Compliance with Nasdaq Bid Price Requirement Salt Lake City, Utah.

Key Takeaway: SINTX Technologies, Inc. has announced that it has regained compliance with the Nasdaq bid price requirement, a significant milestone for the company. The compliance was confirmed in a notice from Nasdaq on June 11, 2024, effectively closing a previously announced listing matter. However, SINTX remains under a Mandatory Panel Monitor for a year and must maintain the minimum bid price to avoid potential delisting.
Price reaction · baseline $4.6 (2024-06-11 close) · hit after-hours · clean, no other SINT news in the window
day 0 close · peak
+3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • SINTX Technologies has regained compliance with Nasdaq's bid price requirement.
  • The company has closed the previously announced listing matter.
  • SINTX has a strong history of developing advanced ceramic materials for medical applications.

CONCERNS & RISKS

  • SINTX is under a Mandatory Panel Monitor for one year.
  • Failure to meet the $1.00 bid price threshold for 30 consecutive business days could lead to delisting.

Full Press Release Details

Technologies Regains Compliance with Nasdaq Bid Price Requirement
Lake City, Utah. June 12, 2024 - SINTX Technologies, Inc. (SINTX) (www.sintx.com) (NASDAQ: SINT; "SINTX" or the
"Company"), a manufacturer and developer of advanced ceramic materials and related technologies, today announced that on
June 11, 2024, the Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has evidenced
compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule
5550(a)(2) (the "Bid Price Rule"). Accordingly, the previously announced listing matter has been closed.
Company remains subject to a "Mandatory Panel Monitor," as that term is defined in Listing Rule 5815(d)(4)(B), for a period
of one year from June 11, 2024. If, within the one-year period, the Company fails to satisfy the minimum $1.00 closing bid price threshold
for 30 consecutive business days, Nasdaq will issue a delist determination rather than provide the Company with a grace period to regain
compliance with the Bid Price Rule. In that event, the Company would have the opportunity to request a new hearing to address the deficiency.
SINTX Technologies, Inc.
Technologies is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and
technical applications. SINTX is a global leader in the research, development, and manufacturing of silicon nitride, and its products
have been implanted in humans since 2008. Over the past several years, SINTX has utilized strategic acquisitions and alliances to enter
into new markets. The Company has manufacturing facilities in Utah and Maryland.
press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA),
including, but not limited to, statements regarding SINTX's ability to maintain compliance with the Nasdaq Stock Market's
listing standards, effectively manufacture ceramic products, the market for and benefits of SINTX's ceramic products, SINTX's
ability to effectively compete in the ceramic industry, and other statements that are not based on historical fact. Such forward-looking
statements are subject to a number of risks and uncertainties that may cause actual results to differ from current expectations. Risks
and uncertainties that may cause such differences include, among other things: SINTX's products may not prove to be as effective
as other products currently being commercialized or to be commercialized in the future by competitors; risks inherent in manufacturing
and scaling up to commercial quantities while maintaining quality controls; volatility in the price of SINTX's common stock; the
uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance
of our products once commercialized; SINTX's ability to raise funding and other competitive developments. Readers are cautioned
not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management's
current estimates, projections, expectations and beliefs. There can be no assurance that any of the anticipated results will occur on
a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX's Risk Factors disclosure
in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 27, 2024, and in SINTX's other
filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly
revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.
and Media Inquiries for SINTX:

Frequently Asked Questions

What recent compliance achievement did SINTX Technologies announce?

SINTX Technologies announced compliance with Nasdaq's $1.00 minimum bid price requirement.

What happens if SINTX fails to maintain compliance?

If SINTX fails to meet the $1.00 bid price for 30 consecutive days, Nasdaq may issue a delist determination.

How long will SINTX be monitored by a panel?

SINTX will be monitored by a Mandatory Panel Monitor for one year starting June 11, 2024.

What products does SINTX Technologies specialize in?

SINTX specializes in advanced ceramic materials and technologies for medical and technical applications.

When was SINTX's product first implanted in humans?

SINTX's products have been implanted in humans since 2008.

Last updated: Jun 12, 2024